Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
SCM Life Sciences
investment firm
About
SCM Lifescience is a biotechnology company established with the vision of developing treatment options for difficult to treat diseases
- Seoul,Seoul-t'ukpyolsi,South Korea
- http://scmlifescience.com
Highlights
Details
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Jan 1, 2014
- Operating Status
- Active
- Investor Type
- Venture Capital
SCM Lifescience was established in 2014 with the vision of 'developing treatment options for difficult to treat diseases to provide a new source of hope for patients and contribute to the welfare of humanity as a whole' using proprietary stem cell isolation technology and stem cell production technology.
Investments
Number of Investments
Number of Lead Investments
1
0
SCM Life Sciences has made 1 investments. Their most recent investment was on
Jun 23, 2021, when Vita Therapeutics raised $32M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 23, 2021
Vita Therapeutics
|
Series A | $32M | Biotechnology | — |
Acquisition
SCM Life Sciences has acquired 1 organizations. Their most recent acquisition was Argos Therapeutics on Feb 13, 2019. They acquired Argos Therapeutics for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Feb 13, 2019
Argos Therapeutics
|
Biotechnology | acquisition | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
